We have discovered that an attenuated Salmonella vaccine induces superior levels of protection in mice against challenge with virulent Salmonella, tumoricidal and Leishmaniacidal macrophages, and paradoxically at the same time induces profound immunosuppression of splenic mitogenic and in vitro plaque-forming cell responses. We have shown suppression is active, is mediated by a non-H-@ restricted soluble factor, secreted by two populations of cells: adherent, phagocytic, esterase-positive macrophages, and a second, newly defined population of nonadherent, nonphagocytic, esterase-negative cells that contains 75% mononuclear cells with the characteristics of macrophage precursors. We have shown that suppression is reversed by alphaIFNgamma, by IL-4, and by an inhibitor of reactive nitrogen intermediates (RNI), N-monomethyl L-arginine. Suppressor cells produce RNI in culture, and the three inhibitors of suppression also suppress nitrite accumulation. Thus, nitric oxide or another RNI is induced by the attenuated Salmonella and acts as a suppressor factor. As nitric oxide is also a known tumoricidal and microbicidal factor (for eukaryotic pathogens) secreted by activated macrophages, the hypothesis is formulated that Salmonella induce effector cells which mediate protection and suppression through nitric oxide. It is proposed to further investigate these phenomena by 1) identifying more definitively the suppressor and effector cells in the spleen and peritoneal cavity induced by attenuated Salmonella, and seeing if they are the same or different; 2) examining the cellular and cytokine pathway(s) required for induction of suppression and suppressor cells, and testing if they are similar to or different from the pathways leading to protection and to tumoricidal, microbicidal and NK effector cells; 3) determining the target cell(s) of the macrophage suppressor factor and the nature of the blockage in the cellular and cytokine pathways which normally lead to immune responses; and 4) correlating the capacity of Salmonella vaccines to protect and to suppress with production of reactive nitrogen intermediates (RNI) and reactive oxygen intermediates (ROI). The proposed studies on mechanisms of suppression induced by attenuated Salmonella have application to development of vaccines, as suppression post vaccination may be an unwanted side-effect of inoculation. In a broader context, the studies are of basic interest as they will further define the properties of a population of cells in the monocyte/macrophage lineage which are known to be suppressive, but which could also be effector cells. These same cells may be induced by other inflammatory stimuli that result in a mononuclear response. Thus, these studies may elucidate fundamental relationships between suppressive and potentiating effects of a variety of infectious agents and biological response modifiers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI015613-14
Application #
2060252
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1978-12-01
Project End
1997-04-30
Budget Start
1994-05-01
Budget End
1995-04-30
Support Year
14
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Temple University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Eisenstein, T K (2001) Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule. Microbes Infect 3:1223-31
MacFarlane, A S; Schwacha, M G; Eisenstein, T K (1999) In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infect Immun 67:891-8
Schwacha, M G; Meissler Jr, J J; Eisenstein, T K (1998) Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway. Infect Immun 66:5862-6
Eisenstein, T K; Meissler Jr, J J; Miller, S I et al. (1998) Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect. Vaccine 16:24-32
MacFarlane, A S; Huang, D; Schwacha, M G et al. (1998) Nitric oxide mediates immunosuppression induced by Listeria monocytogenes infection: quantitative studies. Microb Pathog 25:267-77
Schwacha, M G; Eisenstein, T K (1997) Interleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium. Infect Immun 65:4897-903
Huang, D; Schwacha, M G; Eisenstein, T K (1996) Attenuated Salmonella vaccine-induced suppression of murine spleen cell responses to mitogen is mediated by macrophage nitric oxide: quantitative aspects. Infect Immun 64:3786-92
Wallace, P K; Eisenstein, T K; Meissler Jr, J J et al. (1995) Decreases in macrophage mediated antitumor activity with aging. Mech Ageing Dev 77:169-84
Wu, L; Morahan, P S; Hendrzak, J A et al. (1994) Herpes simplex virus type 1 replication and IL-1 beta gene expression in mouse peritoneal macrophages activated in vivo by an attenuated Salmonella typhimurium vaccine or Corynebacterium parvum. Microb Pathog 16:387-99
Eisenstein, T K; Huang, D; Meissler Jr, J J et al. (1994) Macrophage nitric oxide mediates immunosuppression in infectious inflammation. Immunobiology 191:493-502

Showing the most recent 10 out of 25 publications